Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.881 USD | +3.26% | +4.23% | -17.19% |
05-09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.19% | 25.45M | |
+29.60% | 48.16B | |
-0.97% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.16% | 25.59B | |
-23.19% | 18.96B | |
+8.44% | 12.92B | |
+28.77% | 12.03B | |
-1.87% | 11.77B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Oppenheimer Adjusts Oncternal Therapeutics Price Target to $9 From $14, Maintains Outperform Rating